$165.78
0.930.57%
At Close: -
15 minutes delayed
First Trust Amex Biotech Index Fund (ARCA: FBT)
Ticker | Name | Share % | |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc. | 5.22% | |
CORT | Corcept Therapeutics Inc | 4.42% | |
UTHR | United Therapeutic | 4.37% | |
HALO | Halozyme Therapeutics Inc | 4.29% | |
VRTX | Vertex Pharmaceuticals Inc - Common | 3.78% | |
REGN | Regeneron Pharmaceuticals Common Stock Usd.001 | 3.72% | |
BIIB | Bbiogen Inc | 3.72% | |
AMGN | Amgen Inc. | 3.70% | |
AS | Argenx Se Spon Adr Each Rep 1 Ord Shs | 3.66% | |
NTRA | Natera Inc | 3.63% |
The FBT ETF is currently trading at $165.79, which represents a 0.57% change. Over the past 52 weeks, the ETF has traded as high as $166.74 and as low as $130.27.
The expense ratio of FBT is 0.56%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for FBT is 1.15B. This represents the total market value of the assets managed by the ETF.
FBT follows a Mid Cap Growth investment style.
The top holdings of FBT include: ALNY (5.22%), CORT (4.42%), UTHR (4.37%), HALO (4.29%), VRTX (3.78%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for FBT is currently not available.